Feb. 22, 2021
Experts say more than a third of adults have not received recommended cancer screenings during the pandemic – in part due to fear of contracting COVID-19. That worries advocates, who now are urging Americans to get these potentially life-saving procedures. (Photo by Specialist 2nd Class Joseph Moon/U.S. Navy)
PHOENIX – Cancer screenings in the U.S. have plunged since the start of the pandemic almost a year ago, prompting health advocates to increase calls for the public to stop postponing these potentially life-saving procedures.
More than one-third of adults have failed to receive recommended cancer screenings during the pandemic, according to “Cancer Won’t Wait and Neither Should You,” a bulletin published by the American Cancer Society and the National Comprehensive Cancer Network.
Posted on 600
Total national prescription opioid use has declined by 60% from the peak volume in 2011 after another year of double-digit decline that is expected in 2020, according to the latest report from the IQVIA™ Institute for Human Data Science,
Prescription Opioid Trends in the United States: Measuring and Understanding Progress in the Opioid Crisis.
Decreases in prescription opioid volume over the past nine years have been driven by changes in clinical use, regulatory and reimbursement policies, and in progressively more restrictive legislation enacted since 2012. The declines have been greatest in the highest doses of prescription opioids over 90 morphine milligrams equivalents per day which present the highest risk of opioid use disorder.
Dec 17, 2020 13:00 UTC
Prescription Opioid Use in the U.S. has Declined by 60% from 2011 Peak, According to New Report from the IQVIA™ Institute for Human Data Science DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C. (Business Wire) Total national prescription opioid use has declined by 60% from the peak volume in 2011 after another year of double-digit decline that is expected in 2020, according to the latest report from the IQVIA™ Institute for Human Data Science,
Prescription Opioid Trends in the United States: Measuring and Understanding Progress in the Opioid Crisis.
Decreases in prescription opioid volume over the past nine years have been driven by changes in clinical use, regulatory and reimbursement policies, and in progressively more restrictive legislation enacted since 2012. The declines have been greatest in the highest doses of prescription opioids over 90 morphine milligrams equivalents per day which present the highest risk of opioid use disorder.
Report Shows Prescription Opioid Use in US Declined by 60% From 2011 Peak pharmacytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmacytimes.com Daily Mail and Mail on Sunday newspapers.